Perphenazine NDC 33342-449

NDC codes

FDA NDC Directory

Product NDC (as listed)33342-449Labeler and product segments. Claims need a package NDC.

Product NDC at billing width33342-0449Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
33342-449-11	33342044911	100 TABLET in 1 BOTTLE (33342-449-11)Marketed from May 6, 2024
33342-449-15	33342044915	500 TABLET in 1 BOTTLE (33342-449-15)Marketed from May 6, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Perphenazine
Generic name (nonproprietary): perphenazine
Active ingredients: Perphenazine — 4 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Macleods Pharmaceuticals Limited
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212545
Marketing start: May 6, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Phenothiazines (Chemical structure)
Identifiers: Product ID 33342-449_921ea109-cb8a-40b9-a290-53a7fee4988dSPL ID 921ea109-cb8a-40b9-a290-53a7fee4988dSPL set ID 28f0cc81-538c-4a4b-be8d-509428fcbb9cRxCUI 198075, 198076, 198077, 198078UNII FTA7XXY4EZUPC 0333342449153, 0333342448156, 0333342449115, 0333342450111, 0333342448118
Pharmacologic class: Phenothiazine

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N433342044911 followed by a unit qualifier and the quantity

Package 33342-0449-11. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Oct 11, 2024. This label includes a boxed warning.

Indications (excerpt from the label)

INDICATIONS & USAGE Perphenazine is indicated for use in the treatment of schizophrenia and for the control of severe nausea and vomiting in adults. Perphenazine has not been shown effective for the management of behavioral complications in patients with mental retardation.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 212545

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 212545
Product	Strength	Form · route	Labeler	Product NDC
Perphenazine	Perphenazine 8 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-450
Perphenazine	Perphenazine 2 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-448
Perphenazine	Perphenazine 16 mg/1	TabletOral	Macleods Pharmaceuticals Limited	33342-451
Perphenazine	Perphenazine 16 mg/1	TabletOral	REMEDYREPACK INC.	70518-4484